New Key Statistics Module, Z-Score and F-Score
NYSE:TEVA Key Ratios
| Market Cap $ M | 14,395.80 |
| Enterprise Value $ M | 31,233.25 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 5.02 |
| Forward PE Ratio | 5.69 |
| Price/Book | 1.97 |
| Price/Sales | 0.95 |
| Price/Free Cash Flow | 17.60 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 15,846.00 |
| EPS (TTM) $ | -0.47 |
| Beneish M-Score | -2.47 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 77.12 |
| EV-to-EBITDA | 20.05 |
| PEG | -- |
| Shares Outstanding M | 1,132.64 |
| Net Margin (%) | -3.53 |
| Operating Margin % | 20.14 |
| Pre-tax Margin (%) | -3.94 |
| Quick Ratio | 0.69 |
| Current Ratio | 1.02 |
| ROA % (ttm) | -1.29 |
| ROE % (ttm) | -7.52 |
| ROIC % (ttm) | 8.33 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.22 |
| Piotroski F-Score | 5.00 |
| Positive ROA | N |
| Positive CFROA | Y |
| Higher ROA y-y | Y |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | N |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | Y |
| Higher Asset Turnover y-y | Y |
TEVA Number of Guru Trades
TEVA Volume of Guru Trades
Gurus Latest Trades with NYSE:TEVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:TEVA is held by these investors
Total 2
Teva Pharmaceutical Industries Ltd Insider Transactions
No Available Data
News about NYSE:TEVA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers